title: Leveraging the attributes of biologics and small molecules, and releasing the bottlenecks: a new wave of revolution in drug development.
authors.affiliation: a SunLife Biopharma , Morris Plains , NJ , USA.
authors.forename: Charles
authors.initials: C
authors.lastname: Oo
authors.affiliation: b Neikalus Communications , Waldwick , NJ , USA.
authors.forename: Suraj S
authors.initials: SS
authors.lastname: Kalbag
mesh_terms: D000818:Animals; D001688:Biological Products / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D004364:Pharmaceutical Preparations / Q000737:chemistry*
chemical_list: D001688:Biological Products; D004364:Pharmaceutical Preparations
keywords: Biologics; antibody fragments; antibody-drug conjugates; drug development; lymphatic circulation; monoclonal antibodies; peptides; proteins; receptor-mediated drug disposition; small molecules